Evidence map›Paper›PMID 34223924›Full record

ArticleInternational orthopaedics2021

Evaluation of primary hip arthroscopy complications in mid-term follow-up: a multicentric prospective study.

Petr Zeman, Moheb Rafi, Jakub Kautzner

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Cumulative surgeon volume is associated with improved outcomes following hip arthroscopy: A national registry study.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Petr ZemanOrthopaedics and Traumatology Department, University Hospital Pilsen, Pilsen, Czech Republic.
Moheb RafiOrthopaedic Department, Kromeriz Hospital, Kromeriz, Czech Republic.
Jakub KautznerDepartment of Childrens and Adults Orthopaedics and Traumatology 2Nd Medical Faculty, Charles University and Motol Hospital, V Uvalu 84, Prague, 15006, Czech Republic. Kautzner.ortho@gmail.com.ORCID 0000-0001-7163-5773

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHip arthroscopy is a common procedure in hip preservation surgery. Its complication rate is relatively low. This prospective multicentric study evaluates complication rate in patients undergoing primary hip arthroscopy. MATERIALS AND

methodsThe study cohort consisted of 908 patients mean age of 37 years (14-67 years). Patients were prospectively included in the study in the years 2009-2017. All complications were recorded and evaluated. The minimum follow-up was 36 months. Results were statistically evaluated and risk factors for complications were identified.

resultsThe overall complication rate was 7.3% (67/908 cases), the minor complication rate of 4.9% (45/908 cases) and the major complication rate 2.4% (22/908 cases). The most common severe complications were iatrogenic cartilage damage and instrument breakage, while the most common minor complications were perineal hypoaesthesia and heterotopic ossifications. The conversion rate to total hip replacement was 4.2% (39/908 patients).

conclusionHip arthroscopy is a safe procedure with low complication rates. Surgeon training and experience greatly influence the complication rates.

Indexed as

Arthroplasty, Replacement, HipArthroscopyAdolescentAdultAgedFollow-Up StudiesHip JointHumansMiddle AgedProspective StudiesReoperationTreatment OutcomeYoung AdultComplication rateHip arthroscopyHip osteoarthritisHip preservation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.